COMP <GO>
FEMY vs AEMD // PIOTROSKI F-SCORE QUALITY
Femasys Inc. (NASDAQ) VS. Aethlon Medical Inc. (NASDAQ) • 15-METRIC TALLY: FEMY 2
— AEMD 1
▲ PIOTROSKI F-SCORE QUALITY LEADER: FEMY
LAST: $1.36 (-3.90%) • MKT CAP: $11.3M
piotroski-score
4/9
LAST: $5.52 (-0.54%) • MKT CAP: $8.9M
piotroski-score
3/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FEMY VS. AEMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FEMY | AEMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 40.80% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 4/9 | 3/9 | +1.00 | FEMY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 27.5 | 53.5 | -26.03 | AEMD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.3M | $8.9M | $2.5M | FEMY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FEMY REV | AEMD REV | FEMY GROSS % | AEMD GROSS % | FEMY FCF | AEMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.3M | $0 | 62.0% | — | -$19.2M | -$7.0M |
| FY 2024 | $1.6M | $0 | 66.6% | — | -$20.2M | -$7.6M |
| FY 2023 | $1.1M | $0 | — | — | -$11.3M | -$10.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FEMY // BETA —
AEMD // BETA —